NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Vaccine Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Anthrax



Researchers from the United States and South Korea describe findings in anthrax studies



May 10th, 2006

Anthrax research advances have been reported from the United States and South Korea.

Study 1: A human monoclonal antibody to protective antigen protects against inhalation anthrax.

According to recent research from the United States, "Prevention of inhalation anthrax requires early and extended antibiotic therapy, and therefore, alternative treatment strategies are needed.

"We investigated whether a human monoclonal antibody (AVP-21D9) to protective antigen (PA) would protect mice, guinea pigs, and rabbits against anthrax."

"Control animals challenged with Bacillus anthracis Ames spores by the intranasal...


Source: Vaccine Weekly (2006-05-10)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login